https://www.selleckchem.com/pr....oducts/elamipretide-
D-Rd treatment resulted in significantly greater reduction in pain scores as early as cycle 3 ( = .0007 Rd); the magnitude of change was sustained through cycle 12. Reductions in pain with D-Rd were clinically meaningful in patients regardless of age, ECOG status, or depth of response. Similarly, PRO improvements were observed with D-Rd and Rd on the EuroQol 5-dimensional descriptive system visual analog scale score. D-Rd compared with Rd was associated with faster and sustained clinically meaningful improvements in PROs, i
Like
Comment
Share
